Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally.

Literature DB >> 17612676

Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally.

J K Jongman¹, N Jepkes-Bruin, A R Ramdat Misier, W P Beukema, P P H M Delnoy, H Oude Lutttikhuis, J H E Dambrink, J C A Hoorntje, A Elvan.

Abstract

Brugada syndrome is an inherited cardiac disease and is associated with a peculiar pattern on the electrocardiogram and an increased risk of sudden death. Electrical storm is a malignant but rare phenomenon in symptomatic patients with Brugada syndrome. We describe a patient who presented with repetitive ICD discharges during two episodes of recurrent VF. After the initiation of isoproterenol infusion and oral quinidine, the ventricular tachyarrhythmias were successfully suppressed. (Neth Heart J 2007;15:151-4.).

Entities: Chemical Disease Species

Year: 2007 PMID： 17612676 PMCID： PMC1847769 DOI： 10.1007/BF03085972

Source DB: PubMed Journal: Neth Heart J ISSN： 1568-5888 Impact factor: 2.380

18 in total

Review 1. The Brugada syndrome: ionic basis and arrhythmia mechanisms.

Authors: C Antzelevitch
Journal: J Cardiovasc Electrophysiol Date: 2001-02

2. Electrical storm in Brugada syndrome successfully treated using isoprenaline.

Authors: P Maury; P Couderc; M Delay; S Boveda; J Brugada
Journal: Europace Date: 2004-03 Impact factor: 5.214

3. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia.

Authors: A Lukas; C Antzelevitch
Journal: Cardiovasc Res Date: 1996-09 Impact factor: 10.787

4. Successful treatment of electrical storm with oral quinidine in Brugada syndrome.

Authors: Katia Bettiol; Lorella Gianfranchi; Salvatore Scarfò; Federico Pacchioni; Mario Pedaci; Paolo Alboni
Journal: Ital Heart J Date: 2005-07

5. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease.

Authors: H Kasanuki; S Ohnishi; M Ohtuka; N Matsuda; T Nirei; R Isogai; M Shoda; Y Toyoshima; S Hosoda
Journal: Circulation Date: 1997-05-06 Impact factor: 29.690

6. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study.

Authors: Ruben Coronel; Simona Casini; Tamara T Koopmann; Francien J G Wilms-Schopman; Arie O Verkerk; Joris R de Groot; Zahurul Bhuiyan; Connie R Bezzina; Marieke W Veldkamp; André C Linnenbank; Allard C van der Wal; Hanno L Tan; Pedro Brugada; Arthur A M Wilde; Jacques M T de Bakker
Journal: Circulation Date: 2005-11-01 Impact factor: 29.690

7. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.

Authors: Josep Brugada; Ramon Brugada; Charles Antzelevitch; Jeffrey Towbin; Koonlawee Nademanee; Pedro Brugada
Journal: Circulation Date: 2002-01-01 Impact factor: 29.690

8. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors: G X Yan; C Antzelevitch
Journal: Circulation Date: 1999-10-12 Impact factor: 29.690

9. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.

Authors: Pedro Brugada; Ramon Brugada; Lluis Mont; Maximo Rivero; Peter Geelen; Josep Brugada
Journal: J Cardiovasc Electrophysiol Date: 2003-05

10. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

Authors: P Brugada; J Brugada
Journal: J Am Coll Cardiol Date: 1992-11-15 Impact factor: 24.094

19 in total

1. Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders?

Authors: A A M Wilde; P Langendijk
Journal: Neth Heart J Date: 2007 Impact factor: 2.380

2. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.

Authors: Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal: Clin Res Cardiol Date: 2010-03-11 Impact factor: 5.460

Review 3. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors: Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal: Europace Date: 2017-04-01 Impact factor: 5.214

Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally.

Review 1. The Brugada syndrome: ionic basis and arrhythmia mechanisms.

2. Electrical storm in Brugada syndrome successfully treated using isoprenaline.

3. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia.

4. Successful treatment of electrical storm with oral quinidine in Brugada syndrome.

5. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease.

6. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study.

7. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.

8. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

9. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.

10. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

1. Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders?

2. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.

Review 3. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

4. The management of Brugada syndrome unmasked by fever in a patient with cellulitis.

Review 5. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

6. Isoprenaline and quinidine to calm Brugada VF storm.

Review 7. J-wave syndromes: Brugada and early repolarization syndromes.

Review 8. J wave syndromes as a cause of malignant cardiac arrhythmias.

9. Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome.

10. Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally.